(5Z)-5-(6-QUINOXALINYLMETHYLIDENE)-2-[(2,6-DICHLOROPHENYL)AMINO]-1,3-THIAZOL-4(5H)-ONE
    7.
    发明申请
    (5Z)-5-(6-QUINOXALINYLMETHYLIDENE)-2-[(2,6-DICHLOROPHENYL)AMINO]-1,3-THIAZOL-4(5H)-ONE 审中-公开
    (5Z)-5-(6-喹喔啉基甲基)-2 - [(2,6-二氯苯基)氨基] -1,3-噻唑-4(5H) - 酮

    公开(公告)号:US20100286041A1

    公开(公告)日:2010-11-11

    申请号:US12700194

    申请日:2010-02-04

    CPC分类号: C07D417/06

    摘要: Invented is the compound (5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one, and/or pharmaceutically acceptable salts, hydrates, solvates and pro-drugs thereof. Also invented are pharmaceutical compositions containing this compound, methods of preparing this compound and pharmaceutically acceptable salts, hydrates, solvates and pro-drugs thereof. Also invented are methods of using this compound as an inhibitor of hYAK3 proteins.

    摘要翻译: 本发明是化合物(5Z)-5-(6-喹喔啉亚甲基)-2 - [(2,6-二氯苯基)氨基] -1,3-噻唑-4(5H) - 酮,和/或其药学上可接受的盐,水合物 ,溶剂化物和其前体药物。 还发明了含有该化合物的药物组合物,制备该化合物的方法及其药学上可接受的盐,水合物,溶剂化物和其前体药物。 还发明了使用该化合物作为hYAK3蛋白的抑制剂的方法。

    5(Z)-5-(6-quinoxalinylmethylidene)-2-[2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one
    9.
    发明授权
    5(Z)-5-(6-quinoxalinylmethylidene)-2-[2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one 失效
    5(Z)-5-(6-喹喔啉亚甲基)-2- [2,6-二氯苯基]氨基] -1,3-噻唑-4(5H) - 酮

    公开(公告)号:US07674792B2

    公开(公告)日:2010-03-09

    申请号:US11726741

    申请日:2007-03-22

    IPC分类号: A61K31/498 C07D417/06

    CPC分类号: C07D417/06

    摘要: Invented is the compound (5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6 -dichlorophenyl)amino]-1,3-thiazol-4(5H)-one, and/or pharmaceutically acceptable salts, hydrates, solvates and pro-drugs thereof. Also invented are pharmaceutical compositions containing this compound, methods of preparing this compound and pharmaceutically acceptable salts, hydrates, solvates and pro-drugs thereof. Also invented are methods of using this compound as an inhibitor of hYAK3 proteins.

    摘要翻译: 本发明是化合物(5Z)-5-(6-喹喔啉基亚甲基)-2 - [(2,6-二氯苯基)氨基] -1,3-噻唑-4(5H) - 酮,和/或其药学上可接受的盐,水合物 ,溶剂化物和其前体药物。 还发明了含有该化合物的药物组合物,制备该化合物的方法及其药学上可接受的盐,水合物,溶剂化物和其前体药物。 还发明了使用该化合物作为hYAK3蛋白的抑制剂的方法。